AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26449227
Drug: Diazepam (final
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (final dose 0.07 mg/kg)
Trial: 11301566
Drug: Intramuscular progestin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular progestin therapy (medroxyprogesterone acetate)
Trial: 11301566
Drug: Oral progestin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral progestin therapy (medroxyprogesterone acetate)
Trial: 8165049
Drug: Fluoride supplement
RxNorm normalized name: Fluoride supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride supplement (0.013 mmol or 0.25 mg)
Trial: 8877673
Drug: moexipril 7.5
RxNorm normalized name: moexipril 7.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moexipril 7.5 mg/day (in addition to hydrochlorothiazide 25 mg/day)
Trial: 8877673
Drug: verapamil SR
RxNorm normalized name: Dom-Verapamil SR
DrugBank: Verapamil (DB00661)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: verapamil SR 180 mg/day (in addition to hydrochlorothiazide 25 mg/day)
Trial: 8877673
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of moexipril or verapamil SR with low-dose hydrochlorothiazide
Trial: 3777411
Drug: 1% methohexital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% methohexital solution
Trial: 1815115
Drug: 25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg/kg methohexital
Trial: 6222545
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate treatment
Trial: 6222545
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy according to Hammerstein
Trial: 17912104
Drug: Carboxymethylcellulose gel
RxNorm normalized name: carboxymethylcellulose Ophthalmic Gel
DrugBank: Carboxymethylcellulose (DB11059)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboxymethylcellulose gel and Oral-B toothpaste (control)
Trial: 10645799
Drug: PEM regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEM regimen (cisplatin 60 mg/m2 on day 1, etoposide 40 mg/m2 on days 1, 2, and 3, mitomycin-C 7 mg/m2 on day 1)
Trial: 10645799
Drug: Long CF
RxNorm normalized name: californium Cf-249
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long CF regimen (cisplatin 8 mg/m2 on days 1-5, 8-12, 15-19, and 22-26, 5-fluorouracil 300 mg/m2 as a 24 h infusion or oral UFT-E 400 mg/m2 on days 1-28)
Trial: 7438383
Drug: Aspirin (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1.0 g daily)
Trial: 21460508
Drug: Daily bathing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily bathing with chlorhexidine gluconate (CHG) using CHG-impregnated cloths
Trial: 16790200
Drug: Intravenous abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous abciximab bolus
Trial: 17330512
Drug: Tocotrienol-rich vitamin
RxNorm normalized name: tocotrienols / vitamin E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocotrienol-rich vitamin E (TRE) 80 mg
Trial: 17330512
Drug: Tocotrienol-rich vitamin
RxNorm normalized name: tocotrienols / vitamin E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocotrienol-rich vitamin E (TRE) 160 mg
Trial: 11112128
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (200 microg, twice a day for 7 or 8 days)
Trial: 11712620
Drug: Risperidone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (6 mg/day)
Trial: 9169965
Drug: Risperidone (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (16 mg/day)
Trial: 12870569
Drug: Haloperidol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (20 mg/day)
Trial: 3782046
Drug: Haloperidol (flexible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (flexible dose)
Trial: 29439973
Drug: DS-2969b (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DS-2969b (60 mg, 200 mg, 400 mg)
Trial: 27400997
Drug: 50,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50,000 IU vitamin D weekly for 16 weeks
Trial: 21993377
Drug: Self-administered intraperitoneal
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered intraperitoneal bemiparin (BM)
Trial: 8595686
Drug: Lidocaine 2%
RxNorm normalized name: LIDOCAINE 2% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 2% (40 mg)
Trial: 14980919
Drug: Thiopental 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 0.5 mg/kg
Trial: 11710599
Drug: Hyperfractionated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiation therapy (HFX RT) alone
Trial: 11710599
Drug: Hyperfractionated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiation therapy (HFX RT) with concurrent low-dose, daily cisplatin (CDDP)
Trial: 7791060
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (Voltaren Ophthalmic)
Trial: 14594790
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg Fe (control)
Trial: 7665066
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg Fe
Trial: 14594790
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Fe
Trial: 29728858
Drug: ceramide complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ceramide complex cream
Trial: 140084
Drug: placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo cream
Trial: 23713836
Drug: context-focused therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: context-focused therapy
Trial: 22226683
Drug: First two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First two fractions of treatment
Trial: 19100066
Drug: Thiazide diuretics
RxNorm normalized name: althiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiazide diuretics (n = 200)
Trial: 10507245
Drug: Metrifonate 50
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate 50 mg tablet administered in fasting condition
Trial: 10507245
Drug: Metrifonate 50
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate 50 mg tablet administered after high-fat/high-calorie breakfast
Trial: 10507245
Drug: Metrifonate 80
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate 80 mg tablet administered at 8:00 a.m. after overnight fasting
Trial: 10507245
Drug: Metrifonate 80
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate 80 mg tablet administered at 7:00 p.m. (7 h after lunch)
Trial: 10507245
Drug: Metrifonate 80
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate 80 mg tablet administered at 10:00 p.m. (4 h after dinner)
Trial: 10507245
Drug: Metrifonate administration
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate administration (all studies)
Trial: 10507245
Drug: Metrifonate administration
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate administration with food
Trial: 10507245
Drug: Metrifonate administration
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate administration at different times (morning vs evening)
Trial: 6798601
Drug: Morphine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (10 mg/70 kg body weight)
Trial: 27966722
Drug: Coconut oil
RxNorm normalized name: Coconut Oil
DrugBank: Coconut oil (DB14322)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coconut oil (CO) 22.25 g
Trial: 27966722
Drug: Coconut oleogel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coconut oleogel (CG) 25 g
Trial: 26421692
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as Usual (TAU) for 8 weeks
Trial: 12720542
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone 400 mg/day
Trial: 8951189
Drug: (+/‐)‐sotalol multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (+/‐)‐sotalol multiple doses of 80 mg twice daily for 7 consecutive days
Trial: 8951189
Drug: (+/‐)‐sotalol single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (+/‐)‐sotalol single doses of 80 and 160 mg
Trial: 22048129
Drug: 21 mg
RxNorm normalized name: aspirin 421 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21 mg transdermal nicotine
Trial: 17443126
Drug: 14 mg
RxNorm normalized name: iodine 0.14 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14 mg transdermal nicotine
Trial: 1956099
Drug: All transdermal
RxNorm normalized name: all-trans-retinol
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All transdermal nicotine doses
Trial: 29229440
Drug: Doxycycline PEP
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline PEP (200 mg single oral dose within 24 hours after sex)
Trial: 17992062
Drug: PABM-intervention (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PABM-intervention (50 minutes of physical activity twice a week + 50 minutes of behavior modification once a week)
Trial: 11885548
Drug: Full vegetable
RxNorm normalized name: Hydrogenated Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full vegetable fat milk (FVF) (3.5 g fat/dL; 100% vegetable fat from palm-, coconut- and soybean oil)
Trial: 2197158
Drug: Dilevalol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dilevalol (200 mg once daily)
Trial: 6791204
Drug: Naltrexone 200
RxNorm normalized name: NALTREXONE 200 mg / TRIAMCINOLONE 6.5 mg SUBCUTANEOUS IMPLANT [Naltrexone]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 200 mg per day for 1 week
Trial: 19923506
Drug: Systemic lidocaine
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic lidocaine infusion
Trial: 16897236
Drug: Ulinastatin (6000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulinastatin (6000 units x kg(‐1) infusion started 1 h after surgery)
Trial: 16897236
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no protease inhibitors infused)
Trial: 13129862
Drug: Laser photocoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser photocoagulation treatment
Trial: 11075308
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF) administered by dry-powder inhaler (DPI)
Trial: 11075308
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF) administered by metered-dose inhaler with an alternate propellant (MDI-AP)
Trial: 11075308
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF) administered by intravenous (i.v.) route
Trial: 11075308
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate (MF) administered by DPI (separate study with tritiated MF)
Trial: 30662004
Drug: Kefir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kefir (400 mL/day for 4 weeks)
Trial: 18077189
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (CSI) of 40 mg triamcinolone acetonide and 1% lidocaine
Trial: 11212161
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg alendronate (ALN)
Trial: 11212161
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg alendronate (ALN)
Trial: 11212161
Drug: Any dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any dose of alendronate (ALN)
Trial: 11212161
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg and 10 mg alendronate (ALN)
Trial: 25428566
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy with wrist orthosis
Trial: 19013107
Drug: Vinorelbine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine (25 mg/m²) plus gemcitabine (1000 mg/m²) followed by docetaxel (60 mg/m²)
Trial: 19013107
Drug: Paclitaxel (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (225 mg/m²) plus carboplatin (AUC=6)
Trial: 3330028
Drug: Slow-release nifedipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-release nifedipine 20 mg b.d.
Trial: 3330028
Drug: Cyclopenthiazide 0.25
RxNorm normalized name: cyclopenthiazide 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclopenthiazide 0.25 mg with 8.1 mmol potassium daily
Trial: 11579708
Drug: Nifedipine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (40 mg/day orally)
Trial: 778306
Drug: Ribavirin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin (600 mg/day in three divided doses)
Trial: 28877715
Drug: Oral Pirfenidone
RxNorm normalized name: Pirfenidone
DrugBank: Pirfenidone (DB04951)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral Pirfenidone
Trial: 23440694
Drug: IL-10 level
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-10 level >8 pg/ml (pre-IVIG)
Trial: 23440694
Drug: TNFα level
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: TNFα level <2 pg/ml (pre-IVIG)
Trial: 12687332
Drug: gemfibrozil and
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: gemfibrozil and itraconazole combination
Trial: 2187175
Drug: Nebulized metaproterenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized metaproterenol sulfate 5% inhalant solution at a dose of 0.02 mL/kg
Trial: 26156737
Drug: 25 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 μg vitamin D₃/d
Trial: 26156737
Drug: 10 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 μg vitamin D₃/d
Trial: 23816038
Drug: Nurse telephone
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse telephone intervention providing monthly self-management support and quarterly medication management facilitation
Trial: 10779419
Drug: BFM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BFM treatment without cranial irradiation
Trial: 15963199
Drug: Salmeterol 25
RxNorm normalized name: fluticasone-salmeterol 250 mcg-50 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 25 microg/fluticasone propionate 125 microg (two puffs, twice daily) via HFA-MDI
Trial: 15963199
Drug: Salmeterol 50
RxNorm normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50 microg/fluticasone propionate 250 microg (one puff, twice daily) via Diskus inhaler
Trial: 12110626
Drug: Multidrug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidrug treatment (MDT)
Trial: 7437209
Drug: Postoperative analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative analgesic requirement (women)
Trial: 7437209
Drug: Postoperative analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative analgesic requirement (men)
Trial: 24597840
Drug: Luseogliflozin 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luseogliflozin 0.5 mg
Trial: 25855342
Drug: Luseogliflozin 1
RxNorm normalized name: luseogliflozin
DrugBank: Luseogliflozin (DB12214)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Luseogliflozin 1 mg
Trial: 24597840
Drug: Luseogliflozin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luseogliflozin 2.5 mg
Trial: 24597840
Drug: Luseogliflozin 5
RxNorm normalized name: luseogliflozin
DrugBank: Luseogliflozin (DB12214)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Luseogliflozin 5 mg
Trial: 19665366
Drug: Heated intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heated intravenous fluids (via Hotline fluid warmer)
Trial: 11682423
Drug: Epidural ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural ketamine 1 mg/kg combined with 50 microg/kg of morphine
Trial: 11682423
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine 50 microg/kg
Trial: 9021940
Drug: 12 g
RxNorm normalized name: PEG-12 GLYCERYL LAURATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 g fish oil daily for 1 month (27% EPA, 23% DHA) in group 1 (normal renal function)
Trial: 7889965
Drug: Single-dose cefuroxime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose cefuroxime (20 mg/kg intravenously at induction of anaesthesia)
Trial: 7889965
Drug: Three-day course
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-day course of cefuroxime (20 mg/kg intravenously at induction followed by 750 mg t.i.d. for three consecutive days)
Trial: 2851413
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) 7500 AXaU, subcutaneously, starting 2 hours before surgery and continuing for 7 days
Trial: 29504044
Drug: Weekly regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly regimen (60,000 IU weekly)
Trial: 18760150
Drug: Social skills
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social skills treatment program (12-week program with weekly 3-hour group sessions and 1-hour individual sessions)
Trial: 11205721
Drug: Specific and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific and individualized treatment for diastolic heart failure (DHF)
Trial: 8737632
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg sustained release film tablets
Trial: 8737632
Drug: Aqueous solution
RxNorm normalized name: Zephiran Chloride 1:750 Antiseptic Aqueous Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous solution (1 x 1000 mg/d)
Trial: 1410128
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg velnacrine maleate
Trial: 28579313
Drug: Probiotic soy
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic soy milk (200 mL/day)
Trial: 28328980
Drug: Monitoring of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monitoring of cerebral oxygenation by near-infrared spectroscopy with treatment guidelines
Trial: 22638708
Drug: Intensive nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive nutritional intervention comprising regular dietetic counseling and oral nutritional supplementation for 3 months postoperatively
Trial: 18270213
Drug: CCM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCM treatment for 3 months
Trial: 18270213
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment for 3 months
Trial: 22125782
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of prednisolone daily for 14 days
Trial: 14662044
Drug: Paclitaxel 230
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 230 mg/m2 plus topotecan (Arm 3, 13 patients)
Trial: 7675940
Drug: NNC 756
RxNorm normalized name: NNC-55-0396 free base
DrugBank: NNC-55-0396 free base (DB17037)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC 756 (80 mg)
Trial: 2088189
Drug: Ofloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (400 mg) intravenously every 12 h
Trial: 2088189
Drug: Ceftazidime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftazidime (2 g) intravenously every 8 h
Trial: 230654
Drug: Arginine vasotocin
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine vasotocin (AVT) administered subcutaneously at 22.00 and 01.00 h, doses between 2 and 12 micrograms
Trial: 22902795
Drug: Argentine tango
RxNorm normalized name: Argentine canola pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argentine tango dance program (12 months, twice-weekly classes)
Trial: 18414100
Drug: Topical latanoprost
RxNorm normalized name: Latanoprost
DrugBank: Latanoprost (DB00654)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Topical latanoprost applied once daily for 7 days in one-eye trials